Key data on a new class of cardio drugs are coming
GSK's shingles vaccine, new financial investment in women's health, and more biotech news from The Readout
منبع خبری
STAT
GSK's shingles vaccine, new financial investment in women's health, and more biotech news from The Readout
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
Two U.S. measles deaths, the profit motive for women's health, and more Morning Rounds news today
About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see rising health care costs
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study showing reduced dementia risk.
Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments, stressing the profit potential.
“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of “Impossible Choices.”
Sword Health, a digital health company plans to acquire mental health services provider Headspace, according to a regulatory filing.
Two unvaccinated Pennsylvania residents have died from measles, state health officials said Tuesday, the first measles-related deaths in the U.S. this year.
STAT examines Republicans’ health care funding cuts, mRNA science defeats politics, and Medicaid tries out a new way to deny drug coverage.
The number of people working in Massachusetts’ biotech sector fell last year, for the first time since at least 2002. But 2026 is looking up.
In this edition of STAT Health Tech: FDA's plans for regulating generative AI-powered devices, and updates from EPIC's UGM.
Turkish regulators are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging rival drugs.
Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation conflicts with his earlier answers
Deleted public comments on White House proposals, how Trump cuts are reshaping rural health care, and more Morning Rounds news
“I have developed a trained ear for many kinds of ‘humanized’ whale songs especially the types sung by women,” writes physician Caroline Cherston.
Some comments on a proposed OMB research rule have been mysteriously removed from a public-facing government webpage.
New AI technology can help hospitals prevent the controlled substances from being stolen, or abused by staff, but those tools aren't foolproof.
After her aunt died, cancer epidemiologist Kim Johnson looked into screening guidelines for long-term care residents — and found almost nothing.
A scramble to prepare for massive federal cuts across the health care system is hitting rural states like Maine particularly hard.
FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more biotech news
Aon, the big consulting and brokerage house, confirms 2027 is going to be brutal for job-based health care premiums. Aon’s chief actuary said in the news release: “Employers will need…
President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out
New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
The legal theory used to restrict gender-affirming care for minors could be applied broadly, experts say.
“It was only after retiring from mainstream medicine when I fully comprehended the callous limitations of our health care system,” writes Benjamin I. Lee.
Nurse practitioner students face a preceptor shortage, often paying thousands to secure clinical supervision.
FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s head of digital health policy.
A handshake takes only a few seconds but can make a major difference to a patient, an emergency physician writes.
Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.
The drop in soda purchases is meaningful, but not enormous, one of the study's authors said.
Kennedy asks for feedback on new vaccine recommendation categories, how shots are tested.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon
Moderna's stunning surge and drop, AI in scientific writing, and more biotech news from The Readout
Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds
We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement.